Xenetic Biosciences, Inc. (XBIO)

NASDAQ

$1.82

$-0.01

(-0.55%)

Regular Market

Xenetic Biosciences, Inc. (XBIO) Live Price Chart

Last updated: ⁦2026-11-06 20:54:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Xenetic Biosciences, Inc. (XBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.82, with a market capitalization of $4.71M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.58 to $4.94. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.71M
Open	$1.83
Day's High	$1,074.00
Day's Low	$1.58
Previous Close	$1.87
Volume	5.55K
Average Volume	76.26K
P/E Ratio	--
52-Week High	$4.94
52-Week Low	$1.58
Dividend Yield	--
Earnings Date	--

Xenetic Biosciences, Inc. (XBIO) Stock Price Today

Xenetic Biosciences, Inc. (XBIO) is currently trading at $1.82 as of 2026-11-06 20:52:00, down 2.68% ($0.05) from the previous close of $1.87

During today's regular trading session, XBIO has traded between $1.58 and $1,074.00, with a trading volume of 5.55K shares. The current price is near the lower end of today's range.

Xenetic Biosciences, Inc. (XBIO) 7-Day Stock Price Change

Over the past seven days, Xenetic Biosciences, Inc. (XBIO) moved from $2.10 to $1.82, representing a decline of 13.57% ($0.29).

The stock traded between $1.74 and $2.27 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 42.18 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

XBIO 52-Week Price Position

Position in Range: 7.0%

52W Low$1.58

52W High$4.94

XBIO is currently trading at $1.82, placing it 7.0% of the way from its 52-week low of $1.58 to its 52-week high of $4.94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Xenetic Biosciences, Inc. (XBIO)?

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Xenetic Biosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	2
Exchange	NASDAQ
Company Website	https://www.xeneticbio.com

How to Buy Xenetic Biosciences, Inc. (XBIO) Stock on MEXC

Eligible investors can buy real shares of Xenetic Biosciences, Inc. (XBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for XBIO and Place Your Order

Open the RealStocks trading page and search for XBIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Xenetic Biosciences, Inc. (XBIO) stock price today?

Xenetic Biosciences, Inc. (XBIO) is currently trading at $ 1.82, down 2.68% ($0.05) from the previous close of $ 1.87. Intraday prices update in real time during regular trading hours.

2.Is XBIO stock going up or down today?

As of 2026-11-06 20:52:00, XBIO is trading at $ 1.82, down 2.68% ($0.05) from its previous close of $ 1.87. The stock has traded between $ 1.58 and $ 1,074.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is XBIO pre-market price?

As of 2026-11-06 20:52:00, XBIO is trading at $ 1.88 in pre-market trading, up 0.75% ($0.01) from the previous close of $ 1.87. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is XBIO after-hours price?

As of 2026-11-06 20:52:00, XBIO is trading at $ 1.74 in after-hours trading, down 6.70% ($0.13) from the regular-session close of $ 1.87. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is XBIO stock trading now?

XBIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does XBIO sit relative to its 52-week high and low?

Over the past 52 weeks, XBIO has traded between a low of $ 1.58 and a high of $ 4.94. At $ 1.82, the stock is positioned 7.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Xenetic Biosciences, Inc. in?

Xenetic Biosciences, Inc. (XBIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Xenetic Biosciences, Inc.'s market capitalization and where is it listed?

Xenetic Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 4.71M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is XBIO valued in terms of P/E ratio and EPS?

XBIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.06. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Xenetic Biosciences, Inc. pay a dividend?

Xenetic Biosciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.